CA2018875A1 - Production de pyrrolopyrimidines et de leurs intermediaires - Google Patents

Production de pyrrolopyrimidines et de leurs intermediaires

Info

Publication number
CA2018875A1
CA2018875A1 CA2018875A CA2018875A CA2018875A1 CA 2018875 A1 CA2018875 A1 CA 2018875A1 CA 2018875 A CA2018875 A CA 2018875A CA 2018875 A CA2018875 A CA 2018875A CA 2018875 A1 CA2018875 A1 CA 2018875A1
Authority
CA
Canada
Prior art keywords
ring
substituted
hydrocarbon group
same
represents hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2018875A
Other languages
English (en)
Other versions
CA2018875C (fr
Inventor
Hiroshi Akimoto
Takenori Hitaka
Tetsuo Miwa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of CA2018875A1 publication Critical patent/CA2018875A1/fr
Application granted granted Critical
Publication of CA2018875C publication Critical patent/CA2018875C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/50—Three nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CA002018875A 1989-06-14 1990-06-13 Production de pyrrolopyrimidines et de leurs intermediaires Expired - Fee Related CA2018875C (fr)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP150910-1989 1989-06-14
JP15091089 1989-06-14
JP242975-1989 1989-09-18
JP24297589 1989-09-18
JP092391-1990 1990-04-06
JP9239190 1990-04-06

Publications (2)

Publication Number Publication Date
CA2018875A1 true CA2018875A1 (fr) 1990-12-14
CA2018875C CA2018875C (fr) 2000-10-31

Family

ID=27307029

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002018875A Expired - Fee Related CA2018875C (fr) 1989-06-14 1990-06-13 Production de pyrrolopyrimidines et de leurs intermediaires

Country Status (8)

Country Link
US (2) US5349064A (fr)
EP (1) EP0402903A1 (fr)
JP (1) JP2983254B2 (fr)
KR (1) KR0162492B1 (fr)
CN (1) CN1051306C (fr)
CA (1) CA2018875C (fr)
HU (1) HU205358B (fr)
NO (1) NO177057C (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2057635A1 (fr) * 1990-12-14 1992-06-15 Hiroshi Akimoto Composes heterocycliques condenses, leur production et leur utilisation
US5403843A (en) * 1991-08-12 1995-04-04 Takeda Chemical Industries, Ltd. Pyrrolopyrimidinyalglutaminate derivatives and their use
EP0549291A1 (fr) * 1991-12-27 1993-06-30 Takeda Chemical Industries, Ltd. Inhibiteurs de la thymidylate synthase
US5502187A (en) * 1992-04-03 1996-03-26 The Upjohn Company Pharmaceutically active bicyclic-heterocyclic amines
US5416211A (en) * 1992-09-25 1995-05-16 Eli Lilly And Company Process for preparing 5-substituted pyrrolo-[2,3-d]pyrimidines
IL107041A (en) * 1992-09-25 2000-02-17 Lilly Co Eli Process for preparing omega(2-amino-4,7-dihydro-4-oxo-3H-pyrrolo-6-¬2,3-d¾pyrimidin-5-YL)alkarylcarboxylic acids and N-(omega-(2-amino-4,7-dihydro-4-oxo-3H-pyrrolo¬2,3-d¾pyrimidin-5-YL)alk-aroyl-4-glutamic acids
US5278307A (en) * 1992-09-25 1994-01-11 Eli Lilly And Company Process for preparing 4-hydroxypyrrolo(2,3-d)pyrimidine based antifolate compounds and intermediates
EP0766684A4 (fr) * 1994-06-09 1997-07-16 Smithkline Beecham Corp Antagonistes du recepteur de l'endotheline
AU4163197A (en) * 1996-08-30 1998-03-19 Eli Lilly And Company Nonclassical pyrrolo{2,3-d}pyrimidine antifolates
US7863444B2 (en) 1997-03-19 2011-01-04 Abbott Laboratories 4-aminopyrrolopyrimidines as kinase inhibitors
IL135190A (en) * 1997-09-26 2005-03-20 Lilly Co Eli Processes and intermediates useful to make antifolates
PA8474101A1 (es) * 1998-06-19 2000-09-29 Pfizer Prod Inc Compuestos de pirrolo [2,3-d] pirimidina
US6713474B2 (en) 1998-09-18 2004-03-30 Abbott Gmbh & Co. Kg Pyrrolopyrimidines as therapeutic agents
BR9913888A (pt) * 1998-09-18 2002-01-08 Basf Ag Composto, e, métodos de inibir a atividade da proteìna quinase, de tratar um paciente que tenha uma condição que seja mediada pela atividade da proteìna quinase e de diminuir a fertilidade em um paciente
CZ2002936A3 (cs) 1999-09-17 2002-10-16 Abbott Gmbh & Co. Kg Pyrazolopyrimidiny jako terapeutické prostředky
US7071199B1 (en) 1999-09-17 2006-07-04 Abbott Gmbh & Cco. Kg Kinase inhibitors as therapeutic agents
JP4078074B2 (ja) * 1999-12-10 2008-04-23 ファイザー・プロダクツ・インク ピロロ［２，３−ｄ］ピリミジン化合物
KR20050086784A (ko) * 2002-11-26 2005-08-30 화이자 프로덕츠 인크. 이식 거부반응의 치료 방법
US7748422B2 (en) * 2007-05-21 2010-07-06 Bol Stephen J Wheel mounted pump for self-inflating tires
CA2733359C (fr) 2008-08-20 2014-08-05 Pfizer Inc. Composes pyrrolo[2,3-d]pyrimidines
US8385364B2 (en) * 2008-09-24 2013-02-26 Nec Laboratories America, Inc. Distributed message-passing based resource allocation in wireless systems

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB812366A (en) * 1955-08-18 1959-04-22 Wellcome Found Improvements in and relating to derivatives of pyrimidine and the preparation thereof
GB8625019D0 (en) * 1986-10-18 1986-11-19 Wellcome Found Compounds
US4871743A (en) * 1988-01-19 1989-10-03 The Trustees Of Princeton University L-glutamic acid derivatives
JP2830008B2 (ja) * 1988-04-01 1998-12-02 武田薬品工業株式会社 縮合ピリミジン誘導体
NO169490C (no) * 1988-03-24 1992-07-01 Takeda Chemical Industries Ltd Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolopyrimidinderivater

Also Published As

Publication number Publication date
US5496946A (en) 1996-03-05
CN1051306C (zh) 2000-04-12
NO177057C (no) 1995-07-12
CN1103401A (zh) 1995-06-07
NO177057B (no) 1995-04-03
JP2983254B2 (ja) 1999-11-29
KR910000736A (ko) 1991-01-30
NO902628D0 (no) 1990-06-13
US5349064A (en) 1994-09-20
EP0402903A1 (fr) 1990-12-19
HU205358B (en) 1992-04-28
CA2018875C (fr) 2000-10-31
HU903853D0 (en) 1990-11-28
NO902628L (no) 1990-12-17
KR0162492B1 (ko) 1998-12-01
JPH049383A (ja) 1992-01-14

Similar Documents

Publication Publication Date Title
CA2018875A1 (fr) Production de pyrrolopyrimidines et de leurs intermediaires
TW255891B (fr)
ES8607287A1 (es) Un procedimiento para preparar derivados de 1,8-naftiridina
ES8405398A1 (es) Procedimiento para preparar nuevos diazabiciclo-(3.3.1)-nonanos
HUT47128A (en) Process for producing oxetanocins and pharmaceutical compositions comprising such compounds
HUT64944A (en) New aryl-glycide-amide derivatives and method for producing them
ES8703885A1 (es) Un procedimiento para preparar nuevos derivados de cefem.
GR3001994T3 (en) A thiophene derivative and process for preparing the same
ES2004079A6 (es) Procedimiento para la preparacion de derivados aminicos antimicoticos y agrofungicidas
HUT58270A (en) Process for producing amine derivatives and pharmaceutical compositions containing them
ATE148128T1 (de) Anthracyclinglycosid-derivate und verfahren zu ihrer herstellung
CA2230826A1 (fr) Derives de galanthamine et procede de preparation de tels derives
BR9808589A (pt) Processo para produção de nitrato de hexamina cabolto
ES8200113A1 (es) Un procedimiento para la preparacion de derivados de cefalosporina.
DE68924991D1 (de) 2-Pyranon-Derivat und Verfahren zu dessen Herstellung.
GB1501321A (en) Morpholine derivatives and processes for the production thereof
HUP0201195A2 (hu) Új vegyületek, eljárás előállításukra, felhasználásuk pigmentként és kozmetikai készítményekként
ATE154024T1 (de) Neue bis(aminomethyl)phosphinsäure-derivate und verfahren zur herstellung von bis(aminomethyl)phosphinsäure-derivaten
HUP0302903A2 (hu) Eljárás királis vegyületek előállítására
ES2074770T3 (es) Procedimiento de preparacion de derivados de 1,3-dioxano-4,6-diona.
ES8101609A1 (es) Un derivado de 7x-metoxicefalosporina
ES8702340A1 (es) Un procedimiento para la produccion de fluorenos 9-sustituiddos.
DE69129605D1 (de) Verfahren zur Herstellung von N-Alkylpyrazolen
ATE97898T1 (de) Antitumor-substanz, verfahren zu deren herstellung und diese enthaltende antikrebsmittel.
ES398734A1 (es) Un procedimiento para la preparacion de un nuevo derivado de amida de fosforo pentavalente de un compuesto del tipo decefalosporina.

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed